Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrochemical immunosensor-enabled liquid biopsy of extracellular vesicles for diagnosis of metabolic dysfunction-associated steatohepatitis. | medRxiv | 2026 | 42818423 | PubTator, text mining | PubMed |
| Integrated plasma proteomic and metabolomic profiling demonstrated specific proteins and bile acids remodeling after liver transplantation of children with biliary atresia. | Biochim Biophys Acta Proteins Proteom | 2026 | 42777789 | PubTator, text mining | PubMed |
| Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Associated with Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic Study. | Cancers (Basel) | 2026 | 42738370 | PubTator, text mining | PubMed |
| Olink proteomics identifies serum protein biomarkers and an age-stratified diagnostic model for diabetes in Chinese patients. | Front Endocrinol (Lausanne) | 2026 | 42718750 | PubTator, text mining | PubMed |
| S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via noncanonical SREBP2 signaling. | J Clin Invest | 2026 | 42550612 | PubTator, text mining | PubMed |
| Proteomic and amino acid profiling of SK-MEL-30 melanoma reveals metabolic and structural changes. | Anal Biochem | 2026 | 42470940 | PubTator, text mining | PubMed |
| S100A16 as a potential therapeutic target in sepsis-induced acute lung injury. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42456993 | PubTator, text mining | PubMed |
| Lactylation-driven stabilization of the S100A11/ANXA2 complex promotes pancreatic cancer metastasis. | Cell Biol Toxicol | 2026 | 42432264 | PubTator, text mining | PubMed |
| Lactylation shields S100A11 from degradation to promote gastric cancer metastasis. | Cell Oncol (Dordr) | 2026 | 42423863 | PubTator, text mining | PubMed |
| Functional switching of S100A11 in cancer: An exploration based on molecular mechanisms. | Crit Rev Oncol Hematol | 2026 | 42285330 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer. | Neoplasia | 2026 | 42155177 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and transcriptomic data with RT-qPCR validation explores TRPM4-associated gene signatures in osteoarthritis synovium. | Sci Rep | 2026 | 42106542 | PubTator, text mining | PubMed |
| Retraction: The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis. | PLoS One | 2026 | 42013043 | PubTator, text mining | PubMed |
| Bioinformatics combined with machine learning for the identification of malignant transformation markers in colorectal polyps. | Front Mol Biosci | 2026 | 41953046 | PubTator, text mining | PubMed |
| Gordonibacter-associated regulatory T cell dysfunction and S100A11-mediated neural impairment in Hirschsprung's disease: a microbiota-immune-neural axis. | Cell Biosci | 2026 | 41933371 | PubTator, text mining | PubMed |
| Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC. | Sci Adv | 2026 | 41931605 | PubTator, text mining | PubMed |
| Identifying prioritization of potential targets for idiopathic pulmonary fibrosis: Proteome-wide Mendelian randomization and colocalization analyses. | Clinics (Sao Paulo) | 2026 | 41855608 | PubTator, text mining | PubMed |
| Spi-1 proto-oncogene regulates mRNA hypertranscription and malignant progression in head and neck cancer. | Signal Transduct Target Ther | 2026 | 41851070 | PubTator, text mining | PubMed |
| S100A11 regulates microglial inflammatory response in neuropathic pain via H3K27ac-TFEB-mitochondrial autophagy axis. | J Headache Pain | 2026 | 41814168 | PubTator, text mining | PubMed |
| Assessing links between dental fluorosis and oral/systemic health via salivary microbiome in Chinese young adults. | Int Dent J | 2026 | 41759472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers